股票行情快报：创业慧康（300451）2月2日主力资金净卖出10.64万元

Core Viewpoint - The company Chuangying Huikang (300451) has experienced significant declines in revenue and net profit for the first three quarters of 2025, indicating potential challenges in its business operations and financial health [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue was 862 million yuan, a year-on-year decrease of 26.26% [2]. - The net profit attributable to shareholders was -122 million yuan, reflecting a year-on-year decline of 331.69% [2]. - The net profit excluding non-recurring items was -142 million yuan, down 382.12% year-on-year [2]. - In Q3 2025, the company's single-quarter main revenue was 285 million yuan, a decrease of 35.5% year-on-year [2]. - The single-quarter net profit attributable to shareholders was -41.67 million yuan, a decline of 264.2% year-on-year [2]. - The single-quarter net profit excluding non-recurring items was -47.40 million yuan, down 288.66% year-on-year [2]. - The company's debt ratio stood at 20.27%, with investment income of 4.44 million yuan and financial expenses of -5.32 million yuan [2]. - The gross profit margin was reported at 49.87% [2]. Business Operations - The company's main business has shifted from primarily product development and sales to a broader focus on system construction, services, and operations [2]. - Key areas of expansion include smart healthcare, internet medical services, medical IoT, health big data, smart health cities, and innovative solutions for smart medical insurance [2].